CN1275575A - 合成核苷类似物的方法 - Google Patents
合成核苷类似物的方法 Download PDFInfo
- Publication number
- CN1275575A CN1275575A CN00107145A CN00107145A CN1275575A CN 1275575 A CN1275575 A CN 1275575A CN 00107145 A CN00107145 A CN 00107145A CN 00107145 A CN00107145 A CN 00107145A CN 1275575 A CN1275575 A CN 1275575A
- Authority
- CN
- China
- Prior art keywords
- yuan
- heteroaryls
- dmso
- halogen
- alkylidene group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/14—Pyrrolo-pyrimidine radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13365199P | 1999-05-11 | 1999-05-11 | |
| US60/133651 | 1999-05-11 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1275575A true CN1275575A (zh) | 2000-12-06 |
Family
ID=22459680
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN00107145A Pending CN1275575A (zh) | 1999-05-11 | 2000-05-10 | 合成核苷类似物的方法 |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US6271370B1 (2) |
| EP (1) | EP1052264B1 (2) |
| JP (1) | JP2001011092A (2) |
| KR (1) | KR100403900B1 (2) |
| CN (1) | CN1275575A (2) |
| AR (1) | AR028991A1 (2) |
| AT (1) | ATE291582T1 (2) |
| AU (1) | AU3401100A (2) |
| BR (1) | BR0002089A (2) |
| CA (1) | CA2307951A1 (2) |
| CZ (1) | CZ20001710A3 (2) |
| DE (1) | DE60018833D1 (2) |
| HU (1) | HUP0001843A3 (2) |
| ID (1) | ID25992A (2) |
| IL (1) | IL136027A0 (2) |
| IN (1) | IN186850B (2) |
| MX (1) | MXPA00004532A (2) |
| PL (1) | PL340109A1 (2) |
| RU (1) | RU2200738C2 (2) |
| TR (1) | TR200001340A2 (2) |
| YU (1) | YU25500A (2) |
| ZA (1) | ZA200002263B (2) |
Families Citing this family (65)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW200519106A (en) | 2003-05-02 | 2005-06-16 | Novartis Ag | Organic compounds |
| GB0401334D0 (en) | 2004-01-21 | 2004-02-25 | Novartis Ag | Organic compounds |
| GB0411056D0 (en) | 2004-05-18 | 2004-06-23 | Novartis Ag | Organic compounds |
| AU2005267051B2 (en) * | 2004-07-21 | 2011-07-14 | Gilead Sciences, Inc. | Preparation of alkyl-substituted 2-deoxy-2-fluoro-D-ribofuranosyl pyrimidines and purines and their derivatives |
| GB0424284D0 (en) | 2004-11-02 | 2004-12-01 | Novartis Ag | Organic compounds |
| GB0426164D0 (en) | 2004-11-29 | 2004-12-29 | Novartis Ag | Organic compounds |
| WO2006122003A2 (en) * | 2005-05-05 | 2006-11-16 | Ardea Biosciences, Inc. | Diaryl-purine, azapurines and -deazapurines as non-nucleoside reverse transcriptase inhibitors for treatment of hiv |
| GB0510390D0 (en) | 2005-05-20 | 2005-06-29 | Novartis Ag | Organic compounds |
| GB0516313D0 (en) | 2005-08-08 | 2005-09-14 | Argenta Discovery Ltd | Azole derivatives and their uses |
| BRPI0614290A2 (pt) | 2005-08-08 | 2011-03-22 | Argenta Discovery Ltd | derivados de biciclo [ 2.2.1 ] hept-7-ilamina e seus usos |
| RU2421464C2 (ru) | 2005-10-21 | 2011-06-20 | Новартис Аг | Человеческие антитела к il-13 и их терапевтическое применение |
| GB0601951D0 (en) | 2006-01-31 | 2006-03-15 | Novartis Ag | Organic compounds |
| WO2008037477A1 (en) | 2006-09-29 | 2008-04-03 | Novartis Ag | Pyrazolopyrimidines as p13k lipid kinase inhibitors |
| CN101522682A (zh) | 2006-10-30 | 2009-09-02 | 诺瓦提斯公司 | 作为抗炎剂的杂环化合物 |
| PT2229358E (pt) | 2007-12-14 | 2011-06-29 | Pulmagen Therapeutics Asthma Ltd | Indoles e sua utilização terapêutica |
| ES2389752T3 (es) * | 2007-12-14 | 2012-10-31 | Ardea Biosciences, Inc. | Inhibidores de la transcriptasa inversa |
| MX2010007604A (es) | 2008-01-11 | 2010-08-02 | Novartis Ag | Pirimidinas como inhibidores de cinasa. |
| PT2391366E (pt) | 2009-01-29 | 2013-02-05 | Novartis Ag | Benzimidazoles substituídos para o tratamento de astrocitomas |
| GB0902648D0 (en) | 2009-02-17 | 2009-04-01 | Argenta Discovery Ltd | Pharmaceutical compounds and compositions |
| SG174134A1 (en) | 2009-02-17 | 2011-10-28 | Chiesi Farma Spa | Triazolopyridine derivatives as p38 map kinase inhibitors |
| US8927513B2 (en) * | 2009-07-07 | 2015-01-06 | Alnylam Pharmaceuticals, Inc. | 5′ phosphate mimics |
| US8389526B2 (en) | 2009-08-07 | 2013-03-05 | Novartis Ag | 3-heteroarylmethyl-imidazo[1,2-b]pyridazin-6-yl derivatives |
| JP5781510B2 (ja) | 2009-08-12 | 2015-09-24 | ノバルティス アーゲー | ヘテロ環式ヒドラゾン化合物および癌および炎症の処置のためのそれらの使用 |
| PE20121148A1 (es) | 2009-08-17 | 2012-09-07 | Intellikine Llc | Compuestos heterociclicos y usos de los mismos |
| JP5775871B2 (ja) | 2009-08-20 | 2015-09-09 | ノバルティス アーゲー | ヘテロ環式オキシム化合物 |
| GB201009731D0 (en) | 2010-06-10 | 2010-07-21 | Pulmagen Therapeutics Inflamma | Kinase inhibitors |
| WO2012034095A1 (en) | 2010-09-09 | 2012-03-15 | Irm Llc | Compounds and compositions as trk inhibitors |
| US8637516B2 (en) | 2010-09-09 | 2014-01-28 | Irm Llc | Compounds and compositions as TRK inhibitors |
| WO2012107500A1 (en) | 2011-02-10 | 2012-08-16 | Novartis Ag | [1, 2, 4] triazolo [4, 3 -b] pyridazine compounds as inhibitors of the c-met tyrosine kinase |
| WO2012116237A2 (en) | 2011-02-23 | 2012-08-30 | Intellikine, Llc | Heterocyclic compounds and uses thereof |
| WO2012116217A1 (en) | 2011-02-25 | 2012-08-30 | Irm Llc | Compounds and compositions as trk inhibitors |
| EA026655B1 (ru) | 2011-09-15 | 2017-05-31 | Новартис Аг | 6-ЗАМЕЩЕННЫЕ 3-(ХИНОЛИН-6-ИЛТИО)[1,2,4]ТРИАЗОЛО[4,3-a]ПИРИДИНЫ В КАЧЕСТВЕ ИНГИБИТОРОВ c-MET ТИРОЗИНКИНАЗЫ |
| CA2856803A1 (en) | 2011-11-23 | 2013-05-30 | Intellikine, Llc | Enhanced treatment regimens using mtor inhibitors |
| KR20140105459A (ko) | 2011-12-09 | 2014-09-01 | 키에시 파르마슈티시 엣스. 피. 에이. | 키나아제 억제제 |
| DK2788349T3 (en) | 2011-12-09 | 2017-01-30 | Chiesi Farm Spa | kinase inhibitors |
| BR112014013178A2 (pt) | 2011-12-09 | 2017-06-13 | Chiesi Farm Spa | composto, composição farmacêutica e uso de um composto |
| JP2015512425A (ja) | 2012-04-03 | 2015-04-27 | ノバルティス アーゲー | チロシンキナーゼ阻害剤との組合せ製品及びそれらの使用 |
| WO2014001973A1 (en) | 2012-06-29 | 2014-01-03 | Pfizer Inc. | NOVEL 4-(SUBSTITUTED-AMINO)-7H-PYRROLO[2,3-d]PYRIMIDINES AS LRRK2 INHIBITORS |
| EP2968340A4 (en) | 2013-03-15 | 2016-08-10 | Intellikine Llc | COMBINING KINASE INHIBITORS AND USES THEREOF |
| RU2015151886A (ru) | 2013-06-06 | 2017-06-08 | КЬЕЗИ ФАРМАЧЕУТИЧИ С.п.А. | Ингибиторы киназ |
| MA38884A1 (fr) | 2013-09-05 | 2017-06-30 | Hoffmann La Roche | Composé de triazolopyridine, compositions et procédés d'utilisation associés |
| WO2015084804A1 (en) | 2013-12-03 | 2015-06-11 | Novartis Ag | Combination of mdm2 inhibitor and braf inhibitor and their use |
| JP6487921B2 (ja) | 2013-12-17 | 2019-03-20 | ファイザー・インク | ＬＲＲＫ２阻害薬としての新規の３，４−二置換−１Ｈ−ピロロ［２，３−ｂ］ピリジンおよび４，５−二置換−７Ｈ−ピロロ［２，３−ｃ］ピリダジン |
| WO2016011658A1 (en) | 2014-07-25 | 2016-01-28 | Novartis Ag | Combination therapy |
| ES2831416T3 (es) | 2014-07-31 | 2021-06-08 | Novartis Ag | Terapia de combinación de un inhibidor de MET y un inhibidor de EGFR |
| JP2018507236A (ja) | 2015-03-04 | 2018-03-15 | エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ | トリアゾロピリジン化合物及びその使用法 |
| KR102161364B1 (ko) | 2015-09-14 | 2020-09-29 | 화이자 인코포레이티드 | LRRK2 억제제로서 이미다조[4,5-c]퀴놀린 및 이미다조[4,5-c][1,5]나프티리딘 유도체 |
| TW201720828A (zh) | 2015-11-23 | 2017-06-16 | 赫孚孟拉羅股份公司 | 治療性化合物及組合物以及其使用方法 |
| AR107164A1 (es) | 2015-12-23 | 2018-03-28 | Chiesi Farm Spa | INHIBIDORES DE QUINASA p38 |
| EP3394059B1 (en) | 2015-12-23 | 2020-11-25 | Chiesi Farmaceutici S.p.A. | 1-(3-tert-butyl-phenyl)-3-(4-([1,2,4]triazolo[4,3-a]pyridin-6-yloxy)-1,2,3,4-tetrahydro- naphthalen-1-yl)-urea derivatives and their use as p38 mapk inhibitors |
| EP3394058B1 (en) | 2015-12-23 | 2020-10-14 | Chiesi Farmaceutici S.p.A. | N-[3-(3-{4-[[1,2,4]triazolo[4,3-a]pyridin-6-yloxy]-1,2,3,4-tetrahydro-naphthalen-1-yl} -ureido)-phenyl]-methanesulfonamide derivatives and their use as p38 mapk inhibitors |
| JP7034942B2 (ja) | 2016-05-05 | 2022-03-14 | エフ．ホフマン－ラ ロシュ アーゲー | ピラゾール誘導体、その組成物及び治療的使用 |
| CN109890817B (zh) | 2016-09-06 | 2022-06-17 | 豪夫迈·罗氏有限公司 | 8-(氮杂环丁烷-1-基)-[1,2,4]三唑并[1,5-a]吡啶基化合物、其组合物和应用方法 |
| EP3562809B1 (en) | 2016-12-29 | 2021-06-09 | F. Hoffmann-La Roche AG | Pyrazolopyrimidine compounds and methods of use thereof |
| CN110494434B (zh) | 2017-03-14 | 2022-05-24 | 豪夫迈·罗氏有限公司 | 吡唑并氯苯基化合物、其组合物及其使用方法 |
| CN110678467B (zh) | 2017-05-22 | 2023-06-13 | 豪夫迈·罗氏有限公司 | 治疗化合物和组合物及其使用方法 |
| WO2018215389A1 (en) | 2017-05-22 | 2018-11-29 | F. Hoffmann-La Roche Ag | Therapeutic compounds and compositions, and methods of use thereof |
| US10364245B2 (en) | 2017-06-07 | 2019-07-30 | Chiesi Farmaceutici S.P.A. | Kinase inhibitors |
| EP3740488A1 (en) | 2018-01-15 | 2020-11-25 | F. Hoffmann-La Roche AG | Pyrazolopyrimidine compounds as jak inhibitors |
| CN113194752A (zh) | 2018-06-01 | 2021-07-30 | 康奈尔大学 | Pi3k相关疾病或病症的组合疗法 |
| US20200399274A1 (en) | 2019-06-18 | 2020-12-24 | Genentech, Inc. | Tetrazole-substituted pyrazolopyrimidine inhibitors of jak kinases and uses thereof |
| WO2020257143A1 (en) | 2019-06-18 | 2020-12-24 | Genentech, Inc. | Pyrazolopyrimidine aryl ether inhibitors of jak kinases and uses thereof |
| CA3140024A1 (en) | 2019-06-18 | 2020-12-24 | Mark Edward Zak | Pyrazolopyrimidine sulfone inhibitors of jak kinases and uses thereof |
| TW202140550A (zh) | 2020-01-29 | 2021-11-01 | 瑞士商諾華公司 | 使用抗ｔｓｌｐ抗體治療炎性或阻塞性氣道疾病之方法 |
| CN117343119A (zh) * | 2022-06-29 | 2024-01-05 | 上海交通大学 | 一种烷基化核苷、核苷酸、寡核苷酸及其类似物的制备方法 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS61207400A (ja) * | 1985-03-11 | 1986-09-13 | Nippon Zoki Pharmaceut Co Ltd | ヌクレオシド化合物の製造方法 |
| US4751292A (en) | 1985-07-02 | 1988-06-14 | The Plant Cell Research Institute, Inc. | Adamantyl purines |
| US4859677A (en) | 1987-04-17 | 1989-08-22 | University Of Kansas | Nucleoside analogues having antiviral activity |
| US5246931A (en) | 1988-10-25 | 1993-09-21 | Bristol-Myers Squibb Company | Carbocyclic nucleoside analogs |
| US5688778A (en) | 1989-05-15 | 1997-11-18 | Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic | Nucleoside analogs |
| GB8916480D0 (en) | 1989-07-19 | 1989-09-06 | Glaxo Group Ltd | Chemical process |
| US5726302A (en) * | 1989-09-15 | 1998-03-10 | Gensia Inc. | Water soluble adenosine kinase inhibitors |
| US5674998A (en) | 1989-09-15 | 1997-10-07 | Gensia Inc. | C-4' modified adenosine kinase inhibitors |
| US5763596A (en) | 1989-09-15 | 1998-06-09 | Metabasis Therapeutics, Inc. | C-4' modified adenosine kinase inhibitors |
| US5276151A (en) | 1990-02-01 | 1994-01-04 | Emory University | Method of synthesis of 1,3-dioxolane nucleosides |
| US5470857A (en) | 1990-09-14 | 1995-11-28 | Marion Merrell Dow Inc. | Carbocyclic nucleoside analogs useful as immunosuppressants |
| SE9003151D0 (sv) | 1990-10-02 | 1990-10-02 | Medivir Ab | Nucleoside derivatives |
| ZA923640B (en) | 1991-05-21 | 1993-02-24 | Iaf Biochem Int | Processes for the diastereoselective synthesis of nucleosides |
| GB9204015D0 (en) | 1992-02-25 | 1992-04-08 | Wellcome Found | Therapeutic nucleosides |
| TW374087B (en) | 1993-05-25 | 1999-11-11 | Univ Yale | L-2',3'-dideoxy nucleotide analogs as anti-hepatitis B(HBV) and anti-HIV agents |
| WO1996004293A1 (en) * | 1994-08-02 | 1996-02-15 | Banyu Pharmaceutical Co., Ltd. | Antitumor indolopyrrolocarbazoles |
| US5659023A (en) | 1995-02-01 | 1997-08-19 | Gilead Sciences, Inc. | Nucleotide analogues |
| US6214801B1 (en) | 1996-01-23 | 2001-04-10 | The Regents Of The University Of Michigan | Imidazo[1,2-a]pyridine C-nucleosides as antiviral agents |
-
2000
- 2000-05-03 YU YU25500A patent/YU25500A/sh unknown
- 2000-05-08 IL IL13602700A patent/IL136027A0/xx unknown
- 2000-05-08 US US09/566,468 patent/US6271370B1/en not_active Expired - Fee Related
- 2000-05-08 IN IN421MU2000 patent/IN186850B/en unknown
- 2000-05-09 AT AT00303892T patent/ATE291582T1/de not_active IP Right Cessation
- 2000-05-09 CA CA002307951A patent/CA2307951A1/en not_active Abandoned
- 2000-05-09 ZA ZA200002263A patent/ZA200002263B/xx unknown
- 2000-05-09 AR ARP000102222A patent/AR028991A1/es active IP Right Grant
- 2000-05-09 EP EP00303892A patent/EP1052264B1/en not_active Expired - Lifetime
- 2000-05-09 JP JP2000135874A patent/JP2001011092A/ja active Pending
- 2000-05-09 BR BR0002089-3A patent/BR0002089A/pt not_active IP Right Cessation
- 2000-05-09 DE DE60018833T patent/DE60018833D1/de not_active Expired - Lifetime
- 2000-05-10 KR KR10-2000-0024885A patent/KR100403900B1/ko not_active Expired - Fee Related
- 2000-05-10 AU AU34011/00A patent/AU3401100A/en not_active Abandoned
- 2000-05-10 RU RU2000111438/04A patent/RU2200738C2/ru not_active IP Right Cessation
- 2000-05-10 HU HU0001843A patent/HUP0001843A3/hu unknown
- 2000-05-10 CN CN00107145A patent/CN1275575A/zh active Pending
- 2000-05-10 MX MXPA00004532A patent/MXPA00004532A/es unknown
- 2000-05-10 CZ CZ20001710A patent/CZ20001710A3/cs unknown
- 2000-05-10 ID IDP20000389D patent/ID25992A/id unknown
- 2000-05-11 TR TR2000/01340A patent/TR200001340A2/xx unknown
- 2000-05-11 PL PL00340109A patent/PL340109A1/xx not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| US6271370B1 (en) | 2001-08-07 |
| JP2001011092A (ja) | 2001-01-16 |
| DE60018833D1 (de) | 2005-04-28 |
| TR200001340A2 (tr) | 2000-12-21 |
| YU25500A (sh) | 2003-08-29 |
| AU3401100A (en) | 2000-11-16 |
| KR100403900B1 (ko) | 2003-11-01 |
| IN186850B (2) | 2001-11-24 |
| BR0002089A (pt) | 2001-01-02 |
| RU2200738C2 (ru) | 2003-03-20 |
| HUP0001843A3 (en) | 2001-09-28 |
| AR028991A1 (es) | 2003-06-04 |
| MXPA00004532A (es) | 2002-03-08 |
| HU0001843D0 (en) | 2000-07-28 |
| KR20010069193A (ko) | 2001-07-23 |
| ZA200002263B (en) | 2001-12-24 |
| EP1052264A3 (en) | 2001-06-13 |
| IL136027A0 (en) | 2001-05-20 |
| ATE291582T1 (de) | 2005-04-15 |
| HUP0001843A2 (hu) | 2001-06-28 |
| CA2307951A1 (en) | 2000-11-11 |
| EP1052264B1 (en) | 2005-03-23 |
| CZ20001710A3 (cs) | 2001-09-12 |
| ID25992A (id) | 2000-11-16 |
| PL340109A1 (en) | 2000-11-20 |
| EP1052264A2 (en) | 2000-11-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1275575A (zh) | 合成核苷类似物的方法 | |
| JP5831455B2 (ja) | モルホリノ核酸誘導体 | |
| CN1105109C (zh) | 氯代嘧啶中间体 | |
| EP2794575B1 (en) | Synthesis of triazolopyrimidine compounds | |
| CA2859743A1 (en) | Novel processes for preparing triazolo[4,5-d]pyrimidine derivatives and intermediates thereof | |
| JP2017521398A (ja) | 多環式カルバモイルピリドン化合物の合成 | |
| CN117069663B (zh) | 一种瑞博西尼中间体v的合成方法及瑞博西尼的合成方法 | |
| JP2021514371A (ja) | 一酸化窒素を供与するプロスタグランジン類似体の製造方法 | |
| CN114044777B (zh) | 一种磷酸芦可替尼的制备方法 | |
| US9102698B2 (en) | Process for the synthesis of IB-MECA | |
| JPS6222994B2 (2) | ||
| CN1048296C (zh) | 9-氨基喜树碱的制备方法 | |
| CN111574463B (zh) | 一种利格列汀中间体化合物ⅳ | |
| PL188477B1 (pl) | Sposób syntezy pośrednich związków chloropuryny | |
| CN1176097C (zh) | 提纯5'-保护2'-脱氧嘌呤核苷的方法 | |
| CN1268633C (zh) | 吲哚并咔唑苷的制备和分离 | |
| CN1314685C (zh) | 2,6－二卤代嘌呤的制备方法 | |
| HK1033138A (en) | Process for the synthesis of nucleoside analogs | |
| CN111205232B (zh) | 一种替格瑞洛中间体的合成方法 | |
| KR20140071474A (ko) | 5-[2-[7-(트라이플루오로메틸)-5-[4-(트라이플루오로메틸)페닐]피라졸로[1,5-a]피리미딘-3-일]에틴일]-2-피리딘아민의 제조 방법 | |
| WO2024134859A1 (ja) | 製造中間体 | |
| CN118406056A (zh) | 一种氮杂-2-吲哚酮衍生物及其合成方法 | |
| CN1690065A (zh) | 抗病毒剂西多福韦新衍生物及中间体 | |
| CN1886414A (zh) | 改进的2－取代腺苷的合成 | |
| AU2011346766A1 (en) | Novel processes for preparing triazolo(4,5-d)pyrimidine derivatives and intermediates thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C06 | Publication | ||
| PB01 | Publication | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication | ||
| REG | Reference to a national code |
Ref country code: HK Ref legal event code: GR Ref document number: 1048746 Country of ref document: HK |
|
| REG | Reference to a national code |
Ref country code: HK Ref legal event code: WD Ref document number: 1033138 Country of ref document: HK |